TisaGenlecleucel in Elderly Patients With First-Relapsed or Primary Refractory Aggressive B-cell Non-Hodgkin Lymphoma
Clinical trial NCT04161118 · TERMINATED
Trial details
- NCT number
- NCT04161118
- Sponsor
- University of Cologne
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-12
- Primary completion
- 2023-02-24
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.